From Alpha to Market Beta in Private Market Funds Investors in private asset funds, such as private equity and private infrastructure funds, aim to select top-performing fund managers. However, by definition, only 25% of funds can be in the top quartile, leaving most investors (Limited Partners, or LPs) with lower-performing funds. Measuring outperformance is crucial for LPs when selecting new …
Bridge to Alpha: Why Private Equity’s Value Bridge Falls Short…
To view this content please login or register (free) Access SIPA Research Log in to renew or change an existing membership. Username Email First Name Last Name Password Password Again Group Seats Enter a number between and . Enter a number or greater. This is the maximum number of people you’ll be able to add to your group. Group Name …
Private Equity Valuations: The Calm Before the Next Surge?
To view this content please login or register (free) Access SIPA Research Log in to renew or change an existing membership. Username Email First Name Last Name Password Password Again Group Seats Enter a number between and . Enter a number or greater. This is the maximum number of people you’ll be able to add to your group. Group Name …
Unlock ICS Compliance with infraMetrics and privateMetrics
The adoption of the Insurance Capital Standard (ICS) by IAIS establishes a new global framework for capital adequacy, providing a risk-sensitive approach to enhance financial stability for Internationally Active Insurance Groups (IAIGs). How infraMetrics and privateMetrics Support ICS Compliance: Market-Aligned Valuation: These platforms provide timely, market-driven data that meets ICS’s Market-Adjusted Valuation (MAV) requirements, ensuring accurate and consistent reporting. Tailored …
How Did the Private Equities Market Perform this September?
Comparing the private2000® Index with the Manufacturing Sector The private2000® index, representing a sample of private company investments across 30 countries, achieved a 0.72% return in September 2024, 4.45% YTD, and an 8.85% annualised return over the past 12 months. Here, we compare it with the PECCS Manufacturing sector (Code: AC06), which has underperformed with a 0.53% monthly return and …
Did Sanofi sell Opella at the right price? A no headache solution to the Doliprane valuation
The sale of 50% of Opella to CD&R by Sanofi in October 2024 was the largest buyout in Europe this year and also the opportunity for last minute intrigue and political drama of which only the French have the secret. After several increases of the bid price, including an 11th hour attempt by PAI to outbid CD&R by a meagre …
- Page 1 of 2
- 1
- 2